Zydus Cadila gets USFDA nod to market 2 generic drugs

The company has received final approval from the US heath regulator to market Bosentan tablets USP in strengths of 62.5 mg and 125 mg and Trientine Hydrochloride capsules USP in the strength of 250 mg, Zydus Cadila said in a statement.

from Moneycontrol Business News http://bit.ly/2PFMbX8